No abstract

No abstract

No abstract

No abstract

The present study aims to show the importance of patents as an instrument of technological innovation and to assess the relevance of technology of PEMFC in Brazil by means of the technological monitoring methodology from 1996 to 2005. This study used different Industrial Property Databases (INPI-BR, ESPACENET and DWPI), in order to retrieve the BR applications in each database. Relevant keywords as “fuel cell” were used in combination with specific IPC (H01M8) in order to assess the main applicants, countries, IPCs and technological innovation over time. In Brazil, the country holding more requests in this area is the United States (US) with 53,7% of the patent applications, while Brazil (BR) accounts for 4,4% of the total requests. It was also observed that the North-American company, UTC Fuel Cells comes on top of the list and that there were no patent applications of Brazilian origin (BR) in other countries

No abstract

The present study intends to present the relevance of cellulose by means of the technological foresight study through citing and cited documents from a patent application (WO 9745131 A1) as indicators of innovation. The European database of patents (espacenet) was used, combining keywords and IPC. The major applicants, countries of publication and uses were mapped. The patent requests collected are mainly distributed in the area of polymers to medical devices and therapeutic methods that utilize cellulose. The results obtained revealed that the US was the main country with studies directed to this technological area (18 patent applications) and the major applicant was the company Micro Therapeutics Inc. Therefore, we can understand that this is a promising technology that may reflect in an increase of R&D activities and in the patent deposits in this area.

Population aging and the consequent change in the profile of the age pyramid are already a reality the world over. One undeniable effect of this aging process is the significant increase in the number of people with Alzheimer's disease (AD), which is the most common form of dementia, accounting for around 50%-60% of all cases. AD tends to affect people in their 60 s, becoming progressively more commonplace in older age groups. It is an incurable disease, and patients can live for many years taking medication on a daily basis. This study shows that research into AD is on the rise around the world because the pharmaceutical industry and research institutions are seeking new types of drugs to treat and even cure Alzheimer's patients. By analyzing patent documents, we map out the potential future treatments for this disease, indicating the leading countries and drugs companies that have invested most in a bid to accelerate progress towards new discoveries about the disease and the development of new drugs.